VirusLab: A Tool for Customized SARS-CoV-2 Data Analysis.
COVID-19
SARS-CoV-2
data integration
diagnostics
host population
mutation analysis
virus sequencing
Journal
Biotech (Basel (Switzerland))
ISSN: 2673-6284
Titre abrégé: BioTech (Basel)
Pays: Switzerland
ID NLM: 9918383086206676
Informations de publication
Date de publication:
06 Nov 2021
06 Nov 2021
Historique:
received:
14
09
2021
revised:
26
10
2021
accepted:
02
11
2021
entrez:
13
7
2022
pubmed:
14
7
2022
medline:
14
7
2022
Statut:
epublish
Résumé
Since the beginning of 2020, the COVID-19 pandemic has posed unprecedented challenges to viral data analysis and connected host disease diagnostic methods. We propose VirusLab, a flexible system for analysing SARS-CoV-2 viral sequences and relating them to metadata or clinical information about the host. VirusLab capitalizes on two existing resources: ViruSurf, a database of public SARS-CoV-2 sequences supporting metadata-driven search, and VirusViz, a tool for visual analysis of search results. VirusLab is designed for taking advantage of these resources within a server-side architecture that: (i) covers pipelines based on approaches already in use (ARTIC, Galaxy) but entirely cutomizable upon user request; (ii) predigests analysis of raw sequencing data from different platforms (Oxford Nanopore and Illumina); (iii) gives access to public archives datasets; (iv) supplies user-friendly reporting - making it a tool that can also be integrated into a business environment. VirusLab can be installed and hosted within the premises of any organization where information about SARS-CoV-2 sequences can be safely integrated with information about hosts (e.g., clinical metadata). A system such as VirusLab is not currently available in the landscape of similar providers: our results show that VirusLab is a powerful tool to generate tabular/graphical and machine readable reports that can be integrated in more complex pipelines. We foresee that the proposed system can support many research-oriented and therapeutic scenarios within hospitals or the tracing of viral sequences and their mutational processes within organizations for viral surveillance.
Identifiants
pubmed: 35822801
pii: biotech10040027
doi: 10.3390/biotech10040027
pmc: PMC9245481
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : European Institute of Innovation and Technology
ID : 20663
Références
Lancet Infect Dis. 2021 May;21(5):602
pubmed: 33571446
Nucleic Acids Res. 2021 Jan 8;49(D1):D706-D714
pubmed: 33045727
Zool Res. 2020 Nov 18;41(6):705-708
pubmed: 33045776
Nat Biotechnol. 2020 Mar;38(3):276-278
pubmed: 32055031
Nature. 2021 Jul;595(7869):707-712
pubmed: 34098568
J Mol Biol. 1970 Mar;48(3):443-53
pubmed: 5420325
Virus Evol. 2021 Jul 30;7(2):veab064
pubmed: 34527285
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
Nucleic Acids Res. 2021 Sep 7;49(15):e90
pubmed: 34107016
Elife. 2021 Feb 23;10:
pubmed: 33620031
Brief Bioinform. 2021 Mar 22;22(2):690-700
pubmed: 33057582
Brief Bioinform. 2021 Mar 22;22(2):664-675
pubmed: 33348368
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Bioinformatics. 2020 Jun 1;36(11):3552-3555
pubmed: 32108862
Nucleic Acids Res. 2021 Jan 8;49(D1):D817-D824
pubmed: 33045721
Lancet Microbe. 2020 Jul;1(3):e99-e100
pubmed: 32835336
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Nat Biotechnol. 2021 Oct;39(10):1178-1179
pubmed: 34588690
Bioinformatics. 2020 Dec 21;:
pubmed: 33346830
Nucleic Acids Res. 2019 Jan 8;47(D1):D94-D99
pubmed: 30365038
Genome Biol. 2019 Jan 8;20(1):8
pubmed: 30621750
Nucleic Acids Res. 2016 Jan 4;44(D1):D733-45
pubmed: 26553804
Front Microbiol. 2020 Jun 25;11:1502
pubmed: 32670259
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Brief Bioinform. 2021 Mar 22;22(2):642-663
pubmed: 33147627